Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage
BACKGROUND AND AIMS: In view of increasing therapeutic efficacy, the delivery of hepatitis C virus (HCV) antiviral treatment is expected to increase. Yet practical experience reveals a low rate of treatment, particularly among intravenous drug users. The aim of the present study was to examine the p...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2007-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2007/576765 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559895803592704 |
|---|---|
| author | Romain Moirand Marc Bilodeau Suzanne Brissette Julie Bruneau |
| author_facet | Romain Moirand Marc Bilodeau Suzanne Brissette Julie Bruneau |
| author_sort | Romain Moirand |
| collection | DOAJ |
| description | BACKGROUND AND AIMS: In view of increasing therapeutic efficacy, the delivery of hepatitis C virus (HCV) antiviral treatment is expected to increase. Yet practical experience reveals a low rate of treatment, particularly among intravenous drug users. The aim of the present study was to examine the prevalence of HCV treatment and identify factors associated with HCV treatment in a population of patients evaluated in an academic hepatology outpatient clinic between 2001 and 2002. |
| format | Article |
| id | doaj-art-47f4bfca28af481fa24945de63dd69f1 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2007-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-47f4bfca28af481fa24945de63dd69f12025-02-03T01:28:57ZengWileyCanadian Journal of Gastroenterology0835-79002007-01-0121635536110.1155/2007/576765Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care CoverageRomain Moirand0Marc Bilodeau1Suzanne Brissette2Julie Bruneau3Service des Maladies du Foie, Hôpital Pontchaillou, Rennes, FranceService d’Hépatologie, Hôpital Saint-Luc du Centre hospitalier de l’Université de Montréal, CanadaDépartement de médecine familiale, Université de Montréal, Montreal, Quebec, CanadaDépartement de médecine familiale, Université de Montréal, Montreal, Quebec, CanadaBACKGROUND AND AIMS: In view of increasing therapeutic efficacy, the delivery of hepatitis C virus (HCV) antiviral treatment is expected to increase. Yet practical experience reveals a low rate of treatment, particularly among intravenous drug users. The aim of the present study was to examine the prevalence of HCV treatment and identify factors associated with HCV treatment in a population of patients evaluated in an academic hepatology outpatient clinic between 2001 and 2002.http://dx.doi.org/10.1155/2007/576765 |
| spellingShingle | Romain Moirand Marc Bilodeau Suzanne Brissette Julie Bruneau Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage Canadian Journal of Gastroenterology |
| title | Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage |
| title_full | Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage |
| title_fullStr | Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage |
| title_full_unstemmed | Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage |
| title_short | Determinants of Antiviral Treatment Initiation in a Hepatitis C-infected Population Benefiting from Universal Health Care Coverage |
| title_sort | determinants of antiviral treatment initiation in a hepatitis c infected population benefiting from universal health care coverage |
| url | http://dx.doi.org/10.1155/2007/576765 |
| work_keys_str_mv | AT romainmoirand determinantsofantiviraltreatmentinitiationinahepatitiscinfectedpopulationbenefitingfromuniversalhealthcarecoverage AT marcbilodeau determinantsofantiviraltreatmentinitiationinahepatitiscinfectedpopulationbenefitingfromuniversalhealthcarecoverage AT suzannebrissette determinantsofantiviraltreatmentinitiationinahepatitiscinfectedpopulationbenefitingfromuniversalhealthcarecoverage AT juliebruneau determinantsofantiviraltreatmentinitiationinahepatitiscinfectedpopulationbenefitingfromuniversalhealthcarecoverage |